AstraZeneca plc Price Target Raised to GBX 4,000 at Deutsche Bank (AZN)
Equities research analysts at Deutsche Bank boosted their target price on shares of AstraZeneca plc (LON:AZN) from GBX 3,950 ($67.07) to GBX 4,000 ($67.92) in a research note issued to investors on Friday. The firm currently has a “hold” rating on the stock. Deutsche Bank’s target price would suggest a potential downside of 7.80% from the stock’s previous close.
AstraZeneca plc (LON:AZN) traded down 0.14% during mid-day trading on Friday, hitting GBX 4338.50. The stock had a trading volume of 2,261,840 shares. AstraZeneca plc has a one year low of GBX 442.867 and a one year high of GBX 5750.00. The stock’s 50-day moving average is GBX 4379.56 and its 200-day moving average is GBX 4172.58. The company’s market cap is £54.752 billion.
A number of other analysts have also recently weighed in on AZN. Analysts at Berenberg Bank reiterated a “hold” rating on shares of AstraZeneca plc in a research note on Thursday. They now have a GBX 3,775 ($64.10) price target on the stock. Separately, analysts at Jefferies Group reiterated a “hold” rating on shares of AstraZeneca plc in a research note on Thursday. They now have a GBX 4,790 ($81.34) price target on the stock. Finally, analysts at Swedbank reiterated a “reduce” rating on shares of AstraZeneca plc in a research note on Friday, July 25th. They now have a GBX 3,670.49 ($62.33) price target on the stock. Seven analysts have rated the stock with a sell rating, seventeen have assigned a hold rating and six have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of GBX 4,062.63 ($68.99).
AstraZeneca PLC (LON:AZN) is a global biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.